Cargando…

Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro(®)), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention

BACKGROUND: High-risk percutaneous coronary interventions (PCIs) are associated with a high complication rate, a low procedural success rate and a high restenosis rate, especially in diabetics. We sought to determine whether abciximab (ReoPro(®)) therapy affects long-term clinical outcomes of Korean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sim, Doo Sun, Jeong, Myung Ho, Kim, Weon, Rhew, Jay Young, Yum, Ju Hyup, Kim, Ju Han, Cho, Jeong Gwan, Ahn, Young Keun, Park, Jong Chun, Ahn, Byoung Hee, Kim, Sang Hyung, Kang, Jung Chaee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2003
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531627/ https://www.ncbi.nlm.nih.gov/pubmed/14619381 http://dx.doi.org/10.3904/kjim.2003.18.3.129

Ejemplares similares

The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro(®)) Coated Stent in Patients with Coronary Artery Disease
por: Kim, Weon, et al.
Publicado: (2004)

Anti-inflammatory Effect of Abciximab-Coated Stent in a Porcine Coronary Restenosis Model
por: Hong, Young Joon, et al.
Publicado: (2007)

Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjunctive antithrombotic therapy with abciximab: design and rationale of the High Intensity Transient Signals ReoPro (HITS-RP) study
por: Kretzschmar, Daniel, et al.
Publicado: (2012)

A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab™) in High-Risk Patients with Percutaneous Coronary Intervention
por: Moon, Jae-Youn, et al.
Publicado: (2008)

Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid in a Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2011)

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
por: Iversen, Allan, et al.
Publicado: (2008)

An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention
por: Jeong, Woo Kon, et al.
Publicado: (2003)

Clinical Characteristics of Hypervagotonic Sinus Node Dysfunction
por: Park, Hyung-Wook, et al.
Publicado: (2004)

Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor
por: Cho, Jung Sun, et al.
Publicado: (2010)

The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention
por: Hong, Young Joon, et al.
Publicado: (2003)

The Role of C-Reactive Protein on the Long-Term Clinical Outcome after Primary or Rescue Percutaneous Coronary Intervention
por: Hong, Young Joon, et al.
Publicado: (2003)

Clinical Effects of Calcium Channel Blocker and Angiotensin Converting Enzyme Inhibitor on Endothelial Function and Arterial Stiffness in Patients with Angina Pectoris
por: Kim, Kye Hun, et al.
Publicado: (2009)

Abciximab: Abciximab-induced alveolar haemorrhage: case report
Publicado: (2021)

The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
por: Kim, Seo-Hee, et al.
Publicado: (2021)

Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats
por: Yoon, Namsik, et al.
Publicado: (2013)

A case of successful primary coronary intervention for the total occlusion of left main stem with the aid of abciximab.
por: Jeong, M. H., et al.
Publicado: (2001)

Effects of glycoprotein IIb/IIIa receptor blocker (tirofiban) in acute coronary syndromes angiographic, scintigraphic and molecular biology studies
por: Rizk, A, et al.
Publicado: (2001)

Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure
por: YOON, NAMSIK, et al.
Publicado: (2013)

Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction
por: Choi, Woong Gil, et al.
Publicado: (2011)

Reo de nocturnidad
por: Bryce Echenique, Alfredo, 1939-

A Novel Method of Brachytherapy Using Local Delivery of (99m)Tc–HMPAO for Coronary Stent Restenosis
por: Kim, Weon, et al.
Publicado: (2004)

Long-term Predictive Factors of Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Bae, Eun Hui, et al.
Publicado: (2005)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

Absence of platelet membrane glycoproteins IIb/IIIa from monocytes
Publicado: (1985)

The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
por: Kaluski, Edo
Publicado: (2008)

Receptor GP IIb/IIIa as an Indicator of Risk in Vascular Events
por: Fiodorenko-Dumas, Żanna, et al.
Publicado: (2019)

An Assay of Measuring Platelet Reactivity Using Monoclonal Antibody against Activated Platelet Glycoprotein IIb/IIIa in Patients Taking Clopidogrel
por: Joo, Seung-Jae, et al.
Publicado: (2015)

Diagnostic Value of Nitroglycerin-Induced Headache as a Negative Predictor of Coronary Atherosclerosis
por: Cho, Sook Hee, et al.
Publicado: (2011)

Stress Cardiomyopathy Complicated by Left Ventricular Thrombi and Cerebral Infarctions in a Patient with Essential Thrombocythemia
por: Hwang, Seung Hwan, et al.
Publicado: (2011)

The Effects of QRS Duration and Pacing Sites on the Acute Hemodynamic Changes during Right Ventricular Pacing
por: Hong, Young Joon, et al.
Publicado: (2005)

Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2015)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
por: Suwaidi, Jassim Al, et al.
Publicado: (2001)

A case of myocardial involvement in lung cancer that mimics ST segment elevation in myocardial infarction
por: Kim, Kye Hun, et al.
Publicado: (2014)

Acute right heart failure caused by iatrogenic brachiocephalic arteriovenous fistula following orthopedic surgery
por: Kim, Kye Hun, et al.
Publicado: (2014)

Pulmonary thromboembolism due to severe hyperhomocysteinemia associated with a methyltetrahydrofolate reductase mutation
por: Cho, Kyung Hoon, et al.
Publicado: (2013)

Effect of Abciximab on the Levels of Circulating Microparticles in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty
por: Cha, Jung-Joon, et al.
Publicado: (2013)

Comparison of Coronary Plaque Components between Non-Culprit Lesions in Patients with Acute Coronary Syndrome and Target Lesions in Patients with Stable Angina: Virtual Histology-Intravascular Ultrasound Analysis
por: Hong, Young Joon, et al.
Publicado: (2013)

Alveolar Hemorrhage during Abciximab Infusion
por: Koza, Yavuzer, et al.
Publicado: (2021)

Is Myocardial Infarction in Patients without Significant Stenosis on a Coronary Angiogram as Benign as Believed?
por: Rhew, Shi Hyun, et al.
Publicado: (2012)

Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin II type I receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry—National Institute of Health
por: Ahn, Joon Ho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0sn5jc428pbech2vs3pkaauudn